Al Naqvi:Alex Kleinman of Bioscan is one of the top industry experts in molecular imaging and I am honored to interview him. WMIS has now become the central knowledge dissemination medium for the industry, and will be publishing interviews of … Continue reading
FDA had approved the long-awaited diagnostic/detection test for Alzheimer. The test was developed by Eli Lilly & Co. Lilly acquired Avid, the pioneer company which led the research for the diagnostic test. This test is performed using the PET (Positron … Continue reading
PlanClear: Thank you for joining our Expert Panel and for this interview. Please tell us about your experience in this field? Anwer Rizvi: I founded and was President of what is now known as IBA Molecular, North America, which was one … Continue reading
PlanClear: Thank you for joining our expert panel. Please tell our subscribers about your experience in the industry. Webner: I have been in the Nuclear Medicine industry since 1985. I have played many roles during these years, I have been a line … Continue reading
Professionals are talking about topics such as: Lantheus’s PET cardiology drug enters third phase, what does that mean for SPECT and Rb? Does it make sense to build a 70 MeV to alleviate Rb shortage problem? Would PET cardiology agent run into cyclotron capacity … Continue reading
The pipeline for PET drugs is strong and growing. With many PET drugs in late stage clinical trials and approval process, we can observe several new drugs being introduced in the market within the next 5 years. While there is … Continue reading
INDUSTRY UNDER PRESSURE Crumbling under the forces that only some could have predicted, NM/MI is an industry under seige. The industry barely recovered from the aftermath of DRA and it was hit by a plethora of unfavorable forces. The economy worsened, Moly supply conditions tightened, consolidation continued, … Continue reading